Literature DB >> 25727120

The Affordable Care Act: an opportunity for improving care for substance use disorders?

Katherine E Watkins1, Carrie M Farmer, David De Vries, Kimberly A Hepner.   

Abstract

The Patient Protection and Affordable Care Act (ACA) will greatly increase coverage for treatment of substance use disorders. To realize the benefits of this opportunity, it is critical to develop reliable, valid, and feasible measures of quality to ensure that treatment is accessible and of high quality. The authors review the availability of current quality measures for substance use disorder treatment and conclude there is a pressing need for development, validation, and use of quality measures. They provide recommendations for research and policy changes to increase the likelihood that patients, families, and society benefit from the increased coverage provided by the ACA.

Entities:  

Mesh：

Year:  2014        PMID： 25727120      PMCID： PMC4348000          DOI： 10.1176/appi.ps.201400159

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN： 1075-2730            Impact factor:   3.084


  10 in total

1.  Seizing opportunities under the Affordable Care Act for transforming the mental and behavioral health system.

Authors:  David Mechanic
Journal:  Health Aff (Millwood)       Date:  2012-02       Impact factor: 6.301

2.  The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.

Authors:  Jeffrey A Buck
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

3.  When quality indicators undermine quality: bias in a quality indicator of follow-up for alcohol misuse.

Authors:  Katharine A Bradley; Laura J Chavez; Gwendolyn T Lapham; Emily C Williams; Carol E Achtmeyer; Anna D Rubinsky; Eric J Hawkins; Richard Saitz; Daniel R Kivlahan
Journal:  Psychiatr Serv       Date:  2013-10       Impact factor: 3.084

4.  Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy.

Authors:  John W Finney; Keith Humphreys; Daniel R Kivlahan; Alex H S Harris
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

5.  Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

Authors:  Cindy Parks Thomas; Deborah W Garnick; Constance M Horgan; Kay Miller; Alex H S Harris; Melissa M Rosen
Journal:  J Subst Abuse Treat       Date:  2013-03-13

6.  Criminal justice outcomes after engagement in outpatient substance abuse treatment.

Authors:  Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Margaret T Lee; Lee Panas; Grant A Ritter; Robert Dunigan; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds; David Wright
Journal:  J Subst Abuse Treat       Date:  2013-10-14

7.  Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?

Authors:  Alex H S Harris; Keith Humphreys; Thomas Bowe; Quyen Tiet; John W Finney
Journal:  J Behav Health Serv Res       Date:  2010-01       Impact factor: 1.505

8.  Screening for alcohol and drug use disorders among adults in primary care: a review.

Authors:  Daniel J Pilowsky; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2012-04

9.  Performance measures for substance use disorders--what research is needed?

Authors:  Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Frank McCorry; Constance Weisner
Journal:  Addict Sci Clin Pract       Date:  2012-09-11

10.  Confidentiality protections versus collaborative care in the treatment of substance use disorders.

Authors:  Jennifer K Manuel; Howard Newville; Sandra E Larios; James L Sorensen
Journal:  Addict Sci Clin Pract       Date:  2013-08-26
  10 in total
  7 in total

1.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

2.  Quality of care measures for the management of unhealthy alcohol use.

Authors:  Kimberly A Hepner; Katherine E Watkins; Carrie M Farmer; Lisa Rubenstein; Eric R Pedersen; Harold Alan Pincus
Journal:  J Subst Abuse Treat       Date:  2017-01-26

3.  Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

Authors:  M Eugenia Socías; Nora Volkow; Evan Wood
Journal:  Addiction       Date:  2016-07-13       Impact factor: 6.526

4.  Monitoring opioid addiction and treatment: Do you know if your population is engaged?

Authors:  José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay
Journal:  Drug Alcohol Depend       Date:  2019-07-06       Impact factor: 4.492

5.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

6.  Impact of the Young Adult Dependent Coverage Expansion on Opioid Overdoses and Deaths: a Quasi-Experimental Study.

Authors:  Edouard Coupet; Rachel M Werner; Daniel Polsky; David Karp; M Kit Delgado
Journal:  J Gen Intern Med       Date:  2020-01-02       Impact factor: 5.128

7.  Gender differences in discharge dispositions of emergency department visits involving drug misuse and abuse-2004-2011.

Authors:  Jennifer I Manuel; Jane Lee
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.